Vic Neufeld, co-founder and the former CEO of Aphria Inc. (NASDAQ:APHA) (TSX:APHA), has been announced as a director of Havn Life Sciences Inc. (CSE:HAVN), which went public this week on the Canadian Securities Exchange.
According to the CSE website, “Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.”
Check out Vic Neufeld’s recent interview with Bryan McGovern, Senior Editor at INN below, where he talks about his time at Aphria and more.
Get Real-Time Updates from MJobserver.com
